Oxidative stress in end-stage renal disease: an emerging threat to patient outcome
F. Locatelli(Alessandro Manzoni Hospital), Carmine Zoccali(Biogem), B. Canaud(Université de Montpellier), Peter Stenvinkel(Karolinska Institutet), K.-U. Eckardt, C. Wanner
Cited by 755
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
|The Lancet|2001|1.1k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886